S100B and melanoma: More recently, Alegre et al. evaluated the presence of the melanoma biomarkers melanoma inhibitory activity (MIA) protein, S100B and tyrosinase-related protein 2 (TYRP2) in EXOs derived from serum obtained from stage IV melanoma patients, melanoma-free patients and healthy controls.